Richard Elgen has joined PerkinElmer as vice president and general manager of discovery and research reagents for the firm's Life and Analytical Sciences unit. Elgen joins PerkinElmer from DiscoveRx, where he served as chief scientific officer and executive vice president for research and development.

He holds a PhD in molecular pharmacology from Trent University in Nottingham, UK.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.